Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Kelly Verhelst

Awards & Distinctions

15 Results

2017

CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death : so similar, yet so different

Marie LorkKelly VerhelstRudi Beyaert

A1 Journal Article in CELL DEATH AND DIFFERENTIATION

2016

Molecular mechanisms of mechanotransduction and osteoclastogenesis in arthritis

Laura MeloniRudi BeyaertKelly Verhelst

2015

The multifaceted role of the E3 ubiquitin ligase HOIL-1: beyond linear ubiquitination

Lynn EltonIsabelle CarpentierKelly VerhelstJens StaalRudi Beyaert

A1 Journal Article in IMMUNOLOGICAL REVIEWS

XEDAR activates the non-canonical NF-κB pathway

Kelly VerhelstSandra GardamAlice BorghiMarja KreikeIsabelle CarpentierRudi Beyaert

A1 Journal Article in BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

2014

A20: attractive without showing cleavage

Kelly VerhelstGeert van LooRudi Beyaert

Editorial material

2013

IκB kinase ε (IKKε): a therapeutic target in inflammation and cancer

Kelly VerhelstLynn VerstrepenIsabelle CarpentierRudi Beyaert

A1 Journal Article in BIOCHEMICAL PHARMACOLOGY

2012

A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7

Kelly VerhelstIsabelle CarpentierMarja KreikeLaura MeloniLynn VerstrepenTobias KenscheIvan DikicRudi Beyaert

A1 Journal Article in EMBO JOURNAL

2011

Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis

Saskia LippensS LefebvreBarbara GilbertMozes SzeMichael DevosKelly VerhelstLars VereeckeConor Mc GuireChris GuerinPeter Vandenabeele et al.

A1 Journal Article in CELL DEATH AND DIFFERENTIATION

Linear ubiquitination in NF-κB signaling and inflammation: what we do understand and what we do not

Kelly VerhelstLynn VerstrepenIsabelle CarpentierRudi Beyaert

A1 Journal Article in BIOCHEMICAL PHARMACOLOGY

Regulation of TNF-induced NF-κB activation by different cytoplasmic ubiquitination events

Kelly VerhelstIsabelle CarpentierRudi Beyaert

A1 Journal Article in CYTOKINE & GROWTH FACTOR REVIEWS

TAX1BP1, a ubiquitin-binding adaptor protein in innate immunity and beyond

Lynn VerstrepenKelly VerhelstIsabelle CarpentierRudi Beyaert

A1 Journal Article in TRENDS IN BIOCHEMICAL SCIENCES

2010

Expression, biological activities and mechanisms of action of A20 (TNFAIP3)

Lynn VerstrepenKelly VerhelstGeert van LooIsabelle CarpentierSteven C LeyRudi Beyaert

A1 Journal Article in BIOCHEMICAL PHARMACOLOGY

2009

ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling

Lynn VerstrepenIsabelle CarpentierKelly VerhelstRudi Beyaert

A1 Journal Article in BIOCHEMICAL PHARMACOLOGY

Cellular expression of A20 and ABIN-3 in response to Toll-like receptor-4 stimulation

Kelly VerhelstLynn VerstrepenBeatrice CoornaertIsabelle CarpentierRudi Beyaert

Bookchapter in Toll-like receptors : methods and protocols

2007

LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-kappa B activation

Andy WullaertLynn VerstrepenSofie Van HuffelM Adib-ConquySigrid CornelisMarja KreikeMira HaegmanKarim El BakkouriMatthew SandersKelly Verhelst et al.

A1 Journal Article in JOURNAL OF BIOLOGICAL CHEMISTRY